A CRO managing a Phase III oncology trial across eight countries has forty investigator site initiation meetings recorded over six weeks, three patient advisory board sessions, fifteen KOL interviews, and a pharmacovigilance team fielding adverse event reports from site calls. Every one of those recordings needs to become a document. The question is what kind, under what compliance standard, and how fast. The answer is different for each recording type, and the difference matters in ways that show up in regulatory audits, sponsor deliverables, and safety reporting timelines. Generic transcription tools fail here not because they produce inaccurate text, though they often do, but because they were built for a different problem. A CRO's transcription requirements are a compliance problem as much as a documentation problem.

A medical affairs team finishes 15 KOL interviews across three therapeutic areas. The insights will inform launch strategy, formulary positioning, and a regulatory briefing. The audio sits in a shared folder. Nobody has agreed on a transcription workflow, which verbatim style, which compliance documentation, whether the service has the therapeutic area familiarity to handle what was actually said in those recordings. This is the gap that creates problems downstream. And it's entirely preventable.

A researcher with 25 interviews and a blank NVivo project is not lacking a definition of thematic analysis. What they're looking for is what to do next, in what order, and how to know when they're doing it well. That's what this guide covers.